Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 267-342-2 | CAS number: 67845-93-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1982-1983
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented study report which meets basic scientific principles, basic data given, and comparable to guideline study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: SCHMID, W.; The Micronucleus Test. Mutation Res. 31: 9-15, 1975
- Deviations:
- not specified
- GLP compliance:
- yes
- Remarks:
- The investigation was performed in compliance with; -Non-Clinical Laboratory Studies: Good Laboratory Practice Regulations.- Federal Register. Vol. 431 No. 247. dated December 22, 1978 1 pp. 60013-60025, U.S.A.
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Hexadecyl 3,5-bis-tert-butyl-4-hydroxybenzoate
- EC Number:
- 267-342-2
- EC Name:
- Hexadecyl 3,5-bis-tert-butyl-4-hydroxybenzoate
- Cas Number:
- 67845-93-6
- Molecular formula:
- C31H5403
- IUPAC Name:
- hexadecyl 3,5-di-tert-butyl-4-hydroxybenzoate
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- BATCH-NUMBER: 2/04 lot-Nr. 11-08-10
DESCRIPTION: Powder
STABILITY: Stable at room temperature
STORAGE: The test material and a reserve sample were stored in the dark at room temperature.
SAFETY PRECAUTIONS: Routine hygenic procedures used in handling chemicals were sufficient to assure personnel health and safety.
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:Kleintierfarm Madoerin AG 4414 Fuellinsdorf / Switzerland
- Age at study initiation: Five Weeks
- Weight at study initiation: 20 - 36 g
- Assigned to test groups randomly: Yes
- Fasting period before study: No
- Housing: The experiment was performed under standard laboratory conditions. The animals of the positive control and the treatment groups were housed in groups of 6. The animals of the negative control group were housed in groups of 6 and 4. All animals had Macrolan Type 3 cages with wire mesh tops and standardized granulated soft wood bedding (Source:HLignocel N , Schill AG, 4321 Muttenz / SWitzerland).
- Diet (e.g. ad libitum): The diet consisted of pelleted standard Kliba 343-A mouse maintenance diet, ad libitum (Source: Klingentalmuehle AG, 4403 Kaiseraugst I Switzerland).
- Water (e.g. ad libitum): Tap water was available ad libitum, with water quality according to the requirements of the Schweizerische Lebensmittelbuch.
- Acclimation period: Under test conditions, 7 days, with veterinary examination.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2
- Humidity (%): 55 +/- 10%
- Air changes (per hr): NA
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- For the treated animals, a suspension was prepared by adding the test material to distilled water containing Tween 80 (1%). The suspension was homogenized with a Potter Elvejem Homogenizer (Bender Holbein, 8042 Zuerich, Switzerland). During treatment, homogeneity was maintained by a magnetic stirrer (Auer Bittmann, Switzerland).
- Details on exposure:
- All mice received an oral gavage, once daily, for two consecutive days, thereby exposing the cell population to the test material during two successive S-phases. For the treated animals, a suspension was prepared by adding the test material to distilled water containing Tween 80 (1%). The suspension was homogenized with a Potter Elvejem Homogenizer (Bender Holbein, 8042 Zuerichl Switzerland). During treatment, homogeneity was maintained by a magnetic stirrer (Auer Bittmann, Switzerland). The positive control material was Cyclophosphamide (Source: Serva Chern, Brunschwig, Basel I Switzerland) dissolved in 0.9% NaCl at a concentration of 50 mg.kg-1 body weight, prepared on the day of the experiment. Negative Control: Distilled water with Tween 80 (1%).
The test material and the control materials were administered in a standard volume of 20 ml.kg-1 body weight. - Duration of treatment / exposure:
- Two Days
- Frequency of treatment:
- Once Daily
- Post exposure period:
- Twenty four hours after the second treatment (48 hours after first treatment) the mice were sacrificed. The bone marrow was removed from the femora and slides were prepared for examination.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 200 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 5 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- In the assay, 6 animals of each sex were included in each treatment group (5 animals were evaluated) and 6 animals of each sex in the positive control group (5 animals were evaluated). The negative control group contained 10 animals of each sex (8 animals were evaluated).
- Control animals:
- yes
- Positive control(s):
- The positive control material was Cyclophosphamide (Source: Serva Chern, Brunschwig, Basel / Switzerland) dissolved in 0.9/. NaCl at a concentration of 50 mg.kg-1 body weight, prepared on the day of the experiment.
Examinations
- Tissues and cell types examined:
- BONE MARROW; Polychromatic Erythrocyte (PCE) and Normochromatic Erythrocytes (NCE)
- Details of tissue and slide preparation:
- Both femora were removed and freed of adherent tissue. The proximal end of the femur was cut with scissors and the distal end was left intact. The needle of a plastic syringe) containing 0.2 ml of calf serum* was inserted into the proximal marrow canal. The femur was submerged in 1.5 ml of calf serum in a labeled centrifuge tube. Gentle aspiration and flushing dispersed the bone marrow cells into the serum as a fine homogeneous suspension. The tube containing the bone marrow cells of both femora was centrifuged at 1000 r.p.m. for 5 min. (Centra 7; Kontron AG, Zuerich). The supernatant was removed, leaving a thin layer of serum. The cells of the sediment were carefully mixed by aspiration in a siliconized Pasteur pipette. A small drop of the suspension was smeared onto
the slide and air-dried overnight. Two slides were made per animal. Each slide was identified with: project code, date, dose and the animal number. The following day, the preparations were stained with the panoptic staining method, according to Pappenheim (3). - Evaluation criteria:
- From each animal, one thousand polychromatic erythrocyte (PCE) and one thousand normochromatic erythrocytes (NCE) were screened under the microscope (magnification 1000x) (Wild and Leitz AG, 8002 Zurich/Switzerland), for the incidence of micronuclei. The ratio of polychromatic to normochromatic erythrocytes was based on 1500 cells (PCE + NCE) per slide. The ratio PCE/NeE was determined to measure the toxicity of the test material. The animal number of the slide was obscured to ensure objective evaluation. The numbers of micronucleated erythrocytes at every dose level of the test material were compared with those of the negative control. A significant increase beyond the negative control value would indicate mutag~nic activity through chromosome-breakage induced by the test material.
- Statistics:
- Regression Model: Maximum Likelihood Method (Theoretical Statistics, Cox and Hinkley); Poisson heterogenicity test (Armitage, Statistical Methods in Medical Research, P. 214)
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The mice were clinically examined by a veterinarian during the acclimation period. No disease symptoms were observed. The non-toxicity of the test material was confirmed in the mice species used in the test (LD 50 greater than 5000 mg.kg-1 B.W.) The mouse number 2B died spontaneously after the second application of the test material. After two oral applications of the test material 24 hours apart, no significant difference in the numbers of micronucleated polychromatic or normochromatic erythrocytes was found between the treatment groups and the negative control group (appendix B). No evidence of toxic effects of the test material was observed. As expected, the positive control group showed a significant increase in the number of micronucleated erythrocytes in comparison with the negative control group. Most micronuclei were found in polychromatic erythrocytes. The dose used for the positive control also exhibited toxic effects, as shown by the reduced PCE/NeE ratio (appendix AS).
Applicant's summary and conclusion
- Conclusions:
- None of the three dose levels tested (the highest level was 5000 mg/kg bw) showed any substance-related increase in the numbers of micronucleated polychromatic and normochromatic erythrocytes. Therefore, it can be stated that during the mouse micronucleus assay performed under the conditions described, no chromosome-breakage was detected, and no evidence of potential chromosomal mugenicity could be attributed to CYASORB UV-2908.
- Executive summary:
It can be stated that during the mouse micronucleus assay performed under the conditions described, no chromosome-breakage was detected, and no evidence of potential chromosomal mugenicity could be attributed to CYASORB UV-2908. GLP and SCHMID, W.; The Micronucleus Test. Mutation Res. 31: 9-15, 1975 were followed as guidlines. Test substance doses used in the study were as follows: low dose: 200 mg/kg bw; medium dose: 1000 mg/kg bw; high dose: 5000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.